CircFAM114A2 inhibits the progression of hepatocellular carcinoma via miR-630/HHIP axis.

Mingshuang LaiDeyuan LiMeiliang LiuRuirui ZhangLijun WangWenyi PengHaotian XuSiqian WuSi LiangYe GuAruo NanXiaoyun Zeng

Published in: Cancer medicine (2023)

CircFAM114A2 exerts a tumor suppressor role in HCC through miR-630/HHIP axis, and may be served as a potential diagnostic and therapeutic biomarker for HCC patients.

Keyphrases

cell proliferation
long non coding rna
end stage renal disease
long noncoding rna
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
climate change